Amedica (AMDA) Sets New 1-Year Low at $2.33

Shares of Amedica Co. (NASDAQ:AMDA) reached a new 52-week low during mid-day trading on Friday . The stock traded as low as $2.33 and last traded at $2.60, with a volume of 32300 shares. The stock had previously closed at $2.60.

Several research firms have issued reports on AMDA. Maxim Group restated a “hold” rating on shares of Amedica in a report on Wednesday, January 24th. ValuEngine upgraded Amedica from a “strong sell” rating to a “sell” rating in a report on Friday, February 2nd. Finally, Ladenburg Thalmann Financial Services downgraded Amedica from a “buy” rating to a “neutral” rating in a report on Monday, November 27th.

Amedica (NASDAQ:AMDA) last posted its quarterly earnings data on Tuesday, November 21st. The medical equipment provider reported ($0.93) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.94) by $0.01. The firm had revenue of $2.96 million for the quarter. Amedica had a negative return on equity of 73.86% and a negative net margin of 71.07%. research analysts predict that Amedica Co. will post -6.12 earnings per share for the current fiscal year.

An institutional investor recently raised its position in Amedica stock. Vanguard Group Inc. boosted its stake in shares of Amedica Co. (NASDAQ:AMDA) by 7.1% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 595,866 shares of the medical equipment provider’s stock after buying an additional 39,603 shares during the period. Vanguard Group Inc. owned about 2.26% of Amedica worth $226,000 at the end of the most recent reporting period. 61.76% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Amedica (AMDA) Sets New 1-Year Low at $2.33” was published by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this report on another domain, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The correct version of this report can be read at https://stocknewstimes.com/2018/02/18/amedica-amda-sets-new-1-year-low-at-2-33.html.

About Amedica

Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and corrosion-resistant implant components for hip and knee arthroplasty.

Receive News & Ratings for Amedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedica and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply